Efficacy of Scleral Contact Lenses for Daily Wear for Regular and Irregular Refractive Errors Compared to Habitually Worn Scleral Lenses
Study Details
Study Description
Brief Summary
This study will be done with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It will be fit by the investigators and will be assessed and at one week and 1 month.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Lens fitting/evaluation This study will be done with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It will be fit by the investigators and will be assessed and at one week and 1 month. |
Device: scleral contact lens
Scleral contact lens
|
Outcome Measures
Primary Outcome Measures
- The Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study Lenses [1 month after lens is dispensed]
The primary endpoint of the study is the overall satisfaction and desire to continue wearing the study lenses as measured by a psychometric questionnaire at the completion of the study.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subjects may be male or female, of any race, and at least 18 years old at the time of the pre-treatment examination.
-
Subjects must habitually wear scleral contact lenses for an average wearing time of 6 hours per day.
-
The prospective eye(s) must have refractive hyperopia or myopia from +20.00 to -20.00 diopters sphere (spectacle plane), with up to -10.00 diopters of refractive astigmatism (spectacle plane), as determined by manifest refraction (phoropter or trial frame with a 12.5 mm vertex distance).
-
Subjects must have best spectacle corrected visual acuity of at least 0.5 logMAR in each eye.
-
Subjects must be willing and capable to return for all scheduled follow-up visits for a period of at least 3 months (minimum of 1 month from initial dispensing).
Exclusion Criteria:
-
Female subjects who are pregnant, breast-feeding or intend to become pregnant over the course of the study.
-
Subjects with a history of any of the following medical conditions: collagen vascular disease, autoimmune disease, immunodeficiency diseases, ocular herpes zoster or simplex, endocrine disorders (including, but not limited to active thyroid disorders and diabetes), lupus, and rheumatoid arthritis.
Note: The presence of diabetes (either type 1 or 2), regardless of disease duration, severity or control, will specifically exclude subjects from eligibility.
-
Subjects with active ophthalmic disease or abnormality including glaucoma, chorioretinitis, central retinal artery or vein occlusion, intraocular or ocular infection.
-
Subjects who are participating in any other clinical trial (FDA or other)
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Joseph Barr
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2015W0197
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Lens Fitting/Evaluation |
---|---|
Arm/Group Description | This study was conducted with subjects who already habitually wore scleral contact lenses. The study lens was made with a material that is already widely available and has a new design. It was fit by the investigators and assessed one week and 1 month of wear. scleral contact lens: Scleral contact lens |
Period Title: Overall Study | |
STARTED | 22 |
COMPLETED | 21 |
NOT COMPLETED | 1 |
Baseline Characteristics
Arm/Group Title | Lens Fitting/Evaluation |
---|---|
Arm/Group Description | This study was conducted with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It was fit by the investigators and assessed and at one week and 1 month. scleral contact lens: Scleral contact lens |
Overall Participants | 22 |
Age, Customized (Count of Participants) | |
Age 18 or older |
22
100%
|
Sex: Female, Male (Count of Participants) | |
Female |
9
40.9%
|
Male |
13
59.1%
|
Race and Ethnicity Not Collected (Count of Participants) |
Outcome Measures
Title | The Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study Lenses |
---|---|
Description | The primary endpoint of the study is the overall satisfaction and desire to continue wearing the study lenses as measured by a psychometric questionnaire at the completion of the study. |
Time Frame | 1 month after lens is dispensed |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Lens Fitting/Evaluation |
---|---|
Arm/Group Description | This study was conducted with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It was fit by the investigators and assessed and at one week and 1 month. scleral contact lens: Scleral contact lens |
Measure Participants | 21 |
Preferred test lenses to habitual lenses |
15
68.2%
|
Preferred habitual lenses to test lenses |
2
9.1%
|
No preference |
4
18.2%
|
Adverse Events
Time Frame | Adverse event data was collected at all study visits, including a visit after 1 week and 1 month of lens wear. | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Lens Fitting/Evaluation | |
Arm/Group Description | This study was conducted with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It was fit by the investigators and assessed and at one week and 1 month. scleral contact lens: Scleral contact lens | |
All Cause Mortality |
||
Lens Fitting/Evaluation | ||
Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | |
Serious Adverse Events |
||
Lens Fitting/Evaluation | ||
Affected / at Risk (%) | # Events | |
Total | 0/21 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Lens Fitting/Evaluation | ||
Affected / at Risk (%) | # Events | |
Total | 1/21 (4.8%) | |
Eye disorders | ||
punctate keratitis | 1/21 (4.8%) | 1 |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Jennifer Fogt |
---|---|
Organization | The Ohio State University College of Optometry |
Phone | 614-292-2020 |
Fogt.78@osu.edu |
- 2015W0197